Literature DB >> 11188583

The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis.

J L Poole1, V D Steen.   

Abstract

The health assessment questionnaire (HAQ), a self-administered instrument to determine physical disability, was completed by 211 patients with systemic sclerosis who subsequently received scleroderma examinations. The mean HAQ disability index for the entire group was 0.92. Patients with high skin scores had significantly higher disability indices as compared to patients with low skin scores (p < 0.001). Higher disability indices were found for patients with joint pain, tendon rubs, and contractures. However, the presence of ulcers on the digital tip did not interfere with patients' abilities to function as measured by this scale. Intensive hand evaluations were performed on a subset of these 211 patients with systemic sclerosis (n = 80). Grip strength, thumb abduction, wrist extension, and motion of the index and middle fingers significantly correlated with the HAQ scores (p < 0.01). The findings from this study suggest that patients with systemic sclerosis have significant physical disability. Furthermore, the HAQ appears to be useful in assisting health professionals in quantitating this disability.

Entities:  

Mesh:

Year:  1991        PMID: 11188583     DOI: 10.1002/art.1790040106

Source DB:  PubMed          Journal:  Arthritis Care Res        ISSN: 0893-7524


  61 in total

1.  High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.

Authors:  Peter A McSweeney; Richard A Nash; Keith M Sullivan; Jan Storek; Leslie J Crofford; Roger Dansey; Maureen D Mayes; Kevin T McDonagh; J Lee Nelson; Theodore A Gooley; Leona A Holmberg; C S Chen; Mark H Wener; Katherine Ryan; Julie Sunderhaus; Ken Russell; John Rambharose; Rainer Storb; Daniel E Furst
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

2.  Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis.

Authors:  P A Merkel; N P Silliman; P J Clements; C P Denton; D E Furst; M D Mayes; J E Pope; R P Polisson; J B Streisand; J R Seibold
Journal:  Arthritis Rheum       Date:  2012-10

3.  Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ).

Authors:  C Georges; O Chassany; L Mouthon; K Tiev; C Toledano; O Meyer; Z Marjanovic; C Heneggar; T Papo; B Crickx; D Sereni; J Cabane; D Farge
Journal:  Clin Rheumatol       Date:  2004-06-23       Impact factor: 2.980

4.  High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.

Authors:  Richard A Nash; Peter A McSweeney; Leslie J Crofford; Muneer Abidi; Chien-Shing Chen; J David Godwin; Theodore A Gooley; Leona Holmberg; Gretchen Henstorf; C Fred LeMaistre; Maureen D Mayes; Kevin T McDonagh; Bernadette McLaughlin; Jerry A Molitor; J Lee Nelson; Howard Shulman; Rainer Storb; Federico Viganego; Mark H Wener; James R Seibold; Keith M Sullivan; Daniel E Furst
Journal:  Blood       Date:  2007-04-23       Impact factor: 22.113

5.  Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ).

Authors:  Luiza F Rocha; Roberta G Marangoni; Percival D Sampaio-Barros; Mauricio Levy-Neto; Natalino H Yoshinari; Eloisa Bonfa; Virginia Steen; Sergio C Kowalski
Journal:  Clin Rheumatol       Date:  2013-08-22       Impact factor: 2.980

6.  Radiological hand involvement in systemic sclerosis.

Authors:  J Avouac; H Guerini; J Wipff; N Assous; A Chevrot; A Kahan; Y Allanore
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

7.  Measuring illness behavior in patients with systemic sclerosis.

Authors:  Erin L Merz; Vanessa L Malcarne; Scott C Roesch; Roozbeh Sharif; Brock E Harper; Hilda T Draeger; Emilio B Gonzalez; Deepthi K Nair; Terry A McNearney; Shervin Assassi; Maureen D Mayes
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

8.  Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.

Authors:  Linda Kwakkenbos; Brett D Thombs; Dinesh Khanna; Marie-Eve Carrier; Murray Baron; Daniel E Furst; Karen Gottesman; Frank van den Hoogen; Vanessa L Malcarne; Maureen D Mayes; Luc Mouthon; Warren R Nielson; Serge Poiraudeau; Robert Riggs; Maureen Sauvé; Fredrick Wigley; Marie Hudson; Susan J Bartlett
Journal:  Rheumatology (Oxford)       Date:  2017-08-01       Impact factor: 7.580

9.  What is the relationship between disease activity, severity and damage in a large Canadian systemic sclerosis cohort? Results from the Canadian Scleroderma Research Group (CSRG).

Authors:  Xiangning Fan; Janet Pope; Murray Baron
Journal:  Rheumatol Int       Date:  2009-09-24       Impact factor: 2.631

10.  Predictors of Hand Contracture in Early Systemic Sclerosis and the Effect on Function: A Prospective Study of the GENISOS Cohort.

Authors:  Maryam Buni; Joyce Joseph; Claudia Pedroza; Sam Theodore; Deepthi Nair; Terry A McNearney; Hilda T Draeger; John D Reveille; Shervin Assassi; Maureen D Mayes
Journal:  J Rheumatol       Date:  2019-02-01       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.